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Post-influenza Pneumonia Caused by the USA300 Community-
Associated Methicillin-Resistant Staphylococcus aureus in Korea
Panton-Valentine leukocidin (PVL)-positive USA300 clone has been the most successful 
community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clone 
spreading in North America. In contrast, PVL-negative ST72-CA-MRSA has been 
predominant in Korea, and there has been no report of infections by the USA300 strain 
except only one case report of perianal infection. Here, we describe the first case of 
pneumonia caused by the USA300 strain following pandemic influenza A (H1N1) in Korea. 
A 50-year-old man was admitted with fever and cough and chest radiograph showed 
pneumonic consolidation at the right lower lung zone. He received a ventilator support 
because of respiratory failure. PCR for pandemic influenza A (H1N1) in nasopharyngeal 
swab was positive, and culture of sputum and endotracheal aspirate grew MRSA. Typing 
of the isolate revealed that it was PVL-positive, ST 8-MRSA-SCCmec type IV. The analysis 
of the PFGE patterns showed that this isolate was the same pulsotype as the USA300 strain.
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INTRODUCTION
During the past decade, community-associated methicillin-re-
sistant Staphylococcus aureus (CA-MRSA) has emerged world-
wide. Although there have been some evidences of interconti-
nental spread of major CA-MRSA clones, most CA-MRSA clones 
showed the continent-specific distribution (1). Especially, Pan-
ton-Valentine leukocidin (PVL)-positive USA300 (multilocus 
sequence type [ST] 8) clone has been reported as the most suc-
cessful CA-MRSA clone spreading in the community and in hos-
pitals in North America (1). The study of bacterial isolates from 
purulent skin and soft tissue infections in 11 US emergency de-
partments showed that 59% of all cases of skin and soft tissue 
infections were caused by MRSA and 97% of them were USA300 
(2). A prospective study in San Francisco showed that the USA300 
clone accounted for 78.5% of community-onset and 43.3% of 
hospital-onset MRSA infections indicating that this clone had 
spread rapidly in the community and also in hospitals in this 
region. 
  In contrast, in Korea, PVL-negative ST72-MRSA-SCCmec type 
IV has been reported as the predominant CA-MRSA strain (3-5), 
and there has been no report of infections by the USA300 strain 
except one case report of perianal infection, which was suggest-
ed to be imported from Hawaii (6). Here, we describe the first 
case of pneumonia caused by the USA300 strain following pan-
demic influenza A (H1N1) in Korea.
CASE DESCRIPTION
A 50-yr-old man, who had been healthy except a history of pros-
tatic cancer two years ago, was admitted to Samsung Medical 
Center, Seoul, Korea, on November 21, 2009, with high fever and 
productive cough for three days. He complained of hemoptysis 
with right pleuritic chest pain. His family members and he had 
not traveled to other countries in the previous year. On admis-
sion, he had fever (38.9°C), pulse rate of 65 beats/min, blood 
pressure of 184/154 mmHg, and respiratory rate of 20 breaths/
min. Physical examination showed decreased breath sounds at 
the right lower lung field. Laboratory tests showed 6,860 leuko-
cytes/μL (78.6% neutrophils and 15.2% lymphocytes), hemo-
globin 14.8 g/dL, and platelet 154,000/μL. Other laboratory val-
ues included serum sodium 131 mM/L, blood urea nitrogen Sohn KM, et al.  •  Post-influenza Pneumonia by USA300 in Korea
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14.1 mg/dL, creatinine 1.2 mg/dL, glucose 138 mg/dL, and lac-
tic acid 2.3 mM/L. Arterial blood gas analysis showed pH 7.483, 
pCO2 29.9 mmHg, pO2 59.9 mmHg, HCO3 21.9 mM/L and SaO2 
91.5% on room air. His chest radiograph showed pneumonic 
consolidation at the right lower lung zone. Real-time reverse 
transcription PCR in nasopharyngeal swab was positive for pan-
demic influenza A (H1N1). Gram stain of sputum showed many 
Gram-positive cocci and urinary antigen test for Streptococcus 
pneumoniae was negative. He was given ceftriaxone and levo-
floxacin empirically as well as oseltamivir. On the same day of 
admission, his condition rapidly deteriorated and he was trans-
ferred to the intensive care unit. He received a ventilator support 
after intubation because of respiratory failure. A computed to-
mography scan of the chest showed necrotizing pneumonia in-
volving the right lower lobe (Fig. 1). Culture of sputum and en-
dotracheal aspirate grew MRSA, and it was susceptible to gen-
tamicin, clindamycin, rifampicin, and trimethoprim/sulfa-
methoxazole, however, resistant to ciprofloxacin, erythromycin, 
and tetracycline. The D-test for inducible clindamycin resistance 
was negative. The patient suffered from hemoptysis and sub-
stantial amount of purulent sputum over 2 weeks. He was fully 
recovered after vancomycin treatment for 2 weeks followed by 
oral rifampicin and trimethoprim/sulfamethoxazole for 3 weeks.
  For genotyping of the bacterial isolate, multilocus sequence 
typing (MLST) was carried out by PCR amplification and se-
quencing of seven housekeeping genes (arcC, aroE, glpF, gmk, 
pta, tpi, and yqiL) as previously described (7). The allelic profiles 
and sequence types (STs) were assigned by the MLST web site 
(http://saureus.mlst.net/). SCCmec types were determined by 
the multiplex PCR method. Staphylococcal protein A (spa) typ-
ing was performed as previously described (8). The spa types 
were determined by using Ridom SpaServer (http://spaserver2.
ridom.de/spatypes.shtml). Isolates were screened for the lukF-
PV and lukS-PV genes encoding the components of the PVL 
toxin by PCR amplification of a portion of both the lukS-PV and 
lukF-PV ORFs by using the primer pair luk-PV-1 and luk-PV-2 
designed by Lina et al. (9). Pulsed field gel electrophoresis (PFGE) 
was performed as described previously (10). The PFGE patterns 
were analysed using GelCompar II software (Applied Maths, 
Belgium). Typing of the MRSA isolate from the patient revealed 
that the isolate belonged to MLST ST8, carried SCCmec type IV, 
and was positive for PVL. The spa type was t008 (Ridom Staph 
Type). The analysis of the PFGE patterns showed that this isolate 
was the same pulsotype as the USA300 strain, which was ob-
tained from the Network on Antimicrobial Resistance in Staph-
ylococcus aureus (NARSA), supported under NIAID/NIH con-
tract #HHSN2722 0070 0055C (Fig. 2). The arcA gene in the argi-
nine catabolic mobile element (ACME) which is characteristic 
for the USA300 strain was also positive.
 
DISCUSSION
The USA300 clone has been the most successful CA-MRSA clone 
epidemiologically during the past decade, and has become wide-
ly prevalent strain in the USA. Although there have been increas-
ing reports of the cases of infections by the USA300 clone from 
some European countries (11) and reports of sporadic cases in 
Japan (12), it has been considered that transcontinental spread 
of the USA300 clone has not been successful yet. In Korea, there 
have been a few surveillance studies characterizing CA-MRSA 
strains in Korea, however, the USA300 strain was not found (3, 
4). There has been only one case report of perianal infection 
caused by the USA300 strain, which was suggested to be import-
ed from Hawaii (6). This is the first case report of pneumonia 
caused by the USA300 clone in Korea, which had manifested as 
a post-influenza A (H1N1) pneumonia. 
  We demonstrated that the MRSA isolate from our case was 
Fig. 1. Chest computerized tomography (CT) scan shows a dense consolidation and 
necrotizing areas of the right lower lobe. 
Fig. 2. Pulsed-field gel electrophoresis (PFGE) patterns of MRSA isolate from the pa-
tient and control strains obtained from the Network on Antimicrobial Resistance in 
Staphylococcus aureus (NARSA). PFGE was performed with restriction enzyme SmaI. 
Lane 1, isolate from the patient; lane 2, NRS384 (USA300); lane 3, NRS123 (USA400); 
lane 4, NRS385 (USA500); lane 5, NRS386 (USA700); lane 6, NRS387 (USA800); 
lane 7, NRS483 (USA1000); lane 8, NRS484 (USA1100); M, lambda marker.
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the same strain as the USA300 clone using various genotypic 
methods including MLST, SCCmec typing, spa typing, and PFGE. 
The fact that his family members and he had not traveled to the 
USA suggests the possibility that the USA300 clone might have 
been spreading in Korea, although there has been no report   
revealing the presence of the carriers of the USA300 strain in 
Korea to date (13). 
  Although the USA300 CA-MRSA clone has emerged as a major 
pathogen causing skin and soft tissue infections, it has also been 
associated with invasive diseases including necrotizing pneu-
monia, bacteremia, and osteomyelitis. Furthermore, S. aureus 
has been reported as one of the important pathogens causing 
bacterial pneumonia following pandemic influenza A (H1N1) 
(14) as well as previous pandemic (15) and seasonal influenza 
(16). Post-mortem study of 77 fatal cases due to pandemic influ-
enza A (H1N1) by the Centers for Disease Control and Preven-
tion (CDC) identified 5 cases of MRSA infection, although ge-
notypic information was not given in this report (14). The cases 
of coinfection with CA-MRSA and pandemic influenza A (H1N1) 
have been also reported in other countries including Australia 
(17). This is important because S. aureus is not a common patho-
gen causing community-acquired pneumonia in general; how-
ever we have to consider S. aureus as a very likely pathogen in 
influenza season. Furthermore, animal experiments demon-
strated that antecedent influenza virus infection had a profound 
influence on the morbidity and mortality associated with S. au-
reus pneumonia (18), and clinical data supported this (19). 
  Early appropriate antimicrobial treatment is very important 
for treatment of pneumonia caused by CA-MRSA, because these 
strains are resistant to cephalosporins, most commonly pre-
scribed antibiotics for empirical treatment of community-ac-
quired pneumonia. Previous reports have revealed very high 
mortality rates in the cases of CA-MRSA pneumonia (20). In a 
clinician’s viewpoint, in cases of community-acquired pneumo-
nia occurring during an influenza season, which show the find-
ing of necrotizing pneumonia, the possibility of CA-MRSA should 
be considered as one of the potential pathogens and empirical 
antimicrobial agents targeting CA-MRSA should be selected 
until culture results are reported. Furthermore, considering the 
possibility of the spread of the USA300 clone and the increasing 
incidence of community-associated infections by ST72-MRSA 
in Korea, continuous surveillance of the changing epidemiolo-
gy of CA-MRSA in Korea is essential. 
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